Menu

Daniel LASANOW

PIETRAIN

En résumé

Mes compétences :
API
FDA
Lyophilisation
Management
Production
Purification

Entreprises

  • Siegfried AG - Sr Vice President, Managing Director

    2015 - 2016
  • BASF Pharma - Managing Director

    Levallois-Perret 2012 - 2015
  • BASF Pharma - Production Director & Technologies

    Levallois-Perret 2011 - 2012
  • Nextpharma Technologies - Production Director

    2009 - 2011 Daniel Lasanow



    - Member of Site Direction Committee, Deputy Chairman for Work Council (CE) and Safety Council (CPPT /SHE).
    - Budget definition and control of x million € OPEX and x million € CAPEX (Y 2010).

    Manufacturing: (140 FTE):

    - Build high performing teams to meet corporate goals
    - Re-size and re-organization: deploy transformation & associated social plan.
    - Technical expertise related to Sterile and Aseptic Fill & Finish Products.
    - Proven experience with cGMP, Regulatory & Quality systems.
    - Excellent results with FDA and Japan PMDA inspections.

    Equipments maintenance & Projects management (18 FTE)

    - Equipments maintenance and shutdown management.
    - Technical projects management: annex 1 (1Mio €) , new production line…

    Process Operational Excellence Management (5 FTE):

    - Optimisation of production systems by deployment of Lean Manufacturing, 5S, Kaizen and Kanban methodologies

    Product Development Services (6 FTE):

    - Develop synergies between Manufacturing and Sterile Production Development Centre (R&D).
    - R&D technical projects management: Pre-filled syringes, Ultra-Filtration…
    - Technology and process transfer from development to manufacturing organizations.

    Contract Manufacturing Management :
    - Business development, Contract management & Project management.
  • Lonza - Head of Production

    2002 - 2008 August 2002 – December 2008: Head of API Pharmaceutical Production at Lonza ( Belgium)
    Synthesis – Purification – Isolation (Lyophilisation).


    - Experience in building, developing strategy and driving change in pharmaceutical production organisations. Turn around management of underperforming organisation. Cultural change management.

    - Optimisation of production systems & processes by deployment of Lean Manufacturing philosophy, 5S method, Kaizen and Kanban systems. Implementation of Risks Analysis Methodology System (Unitary operations, equipments, staff...).

    - Strong results in developing cross functional management at all levels of Lonza-Braine site organization. (QA, R&A, R&D, Customer service, Supply Chain HR, Engineering, SHE …).

    - Active participation in budgeting, results in control expenses including large decrease of the work in progress stocks.

    - Strong technical expertise related to pharmaceutical production processes (API): Synthesis / Large scale HPLC purification / Lyophilisation / API Packaging / Cleaning validation /IPC Laboratories....
    Effective problem solving abilities.

    - Ensure and drive for improvements the production operations in compliance with the cGMP, Regulatory & QA Lonza quality system. Results as direct representative for three FDA inspections.

    - Project leader skills: Define User Requirement Specifications and ensure that execution meets expectations : Buildings, Industrial preparative chromatographic columns, freeze dryer …

    - Major improvement of the relationships with the various union representatives.

    - Additional responsability: Lonza Product Manager representative to Millennium Pharmaceutical Inc. / Takeda (Boston, MA, USA).
  • UCB-Bioproducts - Production Manager

    2000 - 2002 April 2000 – August 2002: Production Manager at Lonza-Braine (UCB-Bioproducts).

    - Validation/qualification of peptides manufacturing processes.

    - Transfer of peptides validated processes from R&D to Manufacturing department including in-house expertise, process definitions, manufacturing techniques, procedures, batch-records, analytical methods, and information packages. Manage and develop manufacturing staff by providing training, coaching and and empowerment.

    - Additional responsability: UCB-Bioproducts Customer Product Manager representative to Amgen (Thousand Oaks, CA,USA), Praecis Pharmaceuticals Inc. (Boston, MA, USA) and The Medicines Company (Parsippany, NJ, U.S.A).
  • GSK - Plant Support Manager

    1992 - 2000 March 1992-April 2000: Plant Support Manager / Production Projects Coordinator at GlaxoSmithKline Pharmaceuticals.

    - Active participation in Technology Transfer of pharmaceutical production activities (Flucloxacilline and Temocilline).

    - Scaling-up and optimization of amoxicillin chemical processes. Strong expertise in oral and sterile pharmaceutical manufacturing processes (Chemical synthesis and spray-drying).

    - Qualification and start-up of new equipments (hydrolysis reactors, spray-dryers, distillation columns for recycling of solvents).

    - Validation related to amoxicillin trihydrate scaling-up and optimization processes.
  • Novartis - Junior Scientist

    RUEIL MALMAISON 1987 - 1988 August 1987 – January 1988: Junior Scientist at Novartis, Basel, Switzerland.

    - R&D work performed in organic chemistry, synthesis of macrolides antibiotics derivatives.

Formations

  • Weizmann Institute Of Sciences W.I.S (Rehovot)

    Rehovot 1988 - 1991 Organic Chemistry

    Organic Chemistry - 1988-1991: Weizmann Institute of Sciences (Israël).

    PhD Scientific Researcher in the field of penicillin antibiotics and clavulanic acid derivatives (Not pursued until obtention of diploma).
  • Université Catholique De Louvain (Louvain La Neuve)

    Louvain La Neuve 1982 - 1987 Chimie Organique

Réseau

Annuaire des membres :